コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 g protein (PBP) in a Gram-negative bacillus (Burkholderia pseudomallei).
2 ited by oxyR mutants of Escherichia coli and Burkholderia pseudomallei.
3 on in resistance to the pathogenic bacterium Burkholderia pseudomallei.
4 (BimA) required for actin-based motility of Burkholderia pseudomallei.
5 and rearrangements of the genome relative to Burkholderia pseudomallei.
6 Bordetella spp., Francisella tularensis and Burkholderia pseudomallei.
7 pathogens such as Francisella tularensis and Burkholderia pseudomallei.
8 is caused by the Gram-negative soil bacillus Burkholderia pseudomallei.
9 fection caused by the flagellated saprophyte Burkholderia pseudomallei.
10 t Asia caused by the gram-negative bacterium Burkholderia pseudomallei.
11 transformable Burkholderia thailandensis and Burkholderia pseudomallei.
12 p-like protein in the intracellular pathogen Burkholderia pseudomallei.
13 frequently selected one for the diagnosis of Burkholderia Pseudomallei.
14 the animal pathogens Burkholderia mallei and Burkholderia pseudomallei.
15 caused by the gram-negative soil saprophyte Burkholderia pseudomallei.
17 ommon pathogens were Escherichia coli (28%), Burkholderia pseudomallei (11%), Klebsiella pneumoniae (
18 t response to Gram-negative sepsis caused by Burkholderia pseudomallei, a "Tier 1" biothreat agent an
21 by trials with the highly virulent bacterium Burkholderia pseudomallei, a particularly antimicrobial-
22 llization of glutaryl-CoA dehydrogenase from Burkholderia pseudomallei against 48 different reagents;
23 oan Trichomonas vaginalis, and the bacterium Burkholderia pseudomallei all contain sequences with sig
24 age-like U937 cells following infection with Burkholderia pseudomallei, an intracellular bacterial pa
25 I 20NE and the RapID NF Plus systems with 58 Burkholderia pseudomallei and 23 B. mallei strains for i
29 Staphylococcus aureus, Helicobacter pylori, Burkholderia pseudomallei and Bacillus cereus), illustra
30 Kdo-containing exopolysaccharide produced by Burkholderia pseudomallei and bacteria of the B. cepacia
33 nucleotide polymorphism was used to genotype Burkholderia pseudomallei and Burkholderia mallei isolat
36 ed by the facultative intracellular bacteria Burkholderia pseudomallei and Burkholderia thailandensis
39 ical disease that is caused by the bacterium Burkholderia pseudomallei and is underreported in many c
41 ved and functionally interchangeable between Burkholderia pseudomallei and its relatives B. mallei, B
42 Mice were intranasally infected with viable Burkholderia pseudomallei and killed after 24, 48, or 72
43 L-6, and IL-8 upon subsequent infection with Burkholderia pseudomallei and Salmonella enterica HMBA t
44 ycoproteins of the potential biothreat agent Burkholderia pseudomallei and the closely related but no
47 sely related Burkholderia spp. that includes Burkholderia pseudomallei, B. mallei, and B. thailandens
51 us (rod protein) from S. typhimurium (PrgJ), Burkholderia pseudomallei (BsaK), Escherichia coli (EprJ
53 he structure of the BsaL needle monomer from Burkholderia pseudomallei by nuclear magnetic resonance
55 ntal bacterium and potential biothreat agent Burkholderia pseudomallei causes melioidosis, an often f
58 S system(s) include Acinetobacter baumannii, Burkholderia pseudomallei, Chlamydia trachomatis, Escher
59 ally fatal infection caused by the bacterium Burkholderia pseudomallei Clinical diagnosis of melioido
60 Francisella tularensis, Burkholderia mallei, Burkholderia pseudomallei, Clostridium botulinum, Brucel
61 y B priority pathogens; Burkholderia mallei, Burkholderia pseudomallei, Clostridium perfringens and E
62 h as Bacillus anthracis, Yersinia pestis, or Burkholderia pseudomallei Conventional susceptibility te
63 re of a TTSA needle protein called BsaL from Burkholderia pseudomallei determined by nuclear magnetic
65 During severe gram-negative sepsis caused by Burkholderia pseudomallei, endogenous tissue-type plasmi
68 severe human disease caused by the bacterium Burkholderia pseudomallei, has a wide spectrum of clinic
91 s, instigated by the Gram-negative bacterium Burkholderia pseudomallei, is a frequent cause of pneumo
94 e infection with the environmental bacterium Burkholderia pseudomallei, is being recognised increasin
97 lioidosis, a disease caused by the bacterium Burkholderia pseudomallei, is endemic in southeast Asia
98 fection caused by the gram-negative bacillus Burkholderia pseudomallei, is endemic to Southeast Asia
99 s patients improve when the infecting agent, Burkholderia pseudomallei, is rapidly detected and ident
101 ncing to evaluate 69 independent colonies of Burkholderia pseudomallei isolated from seven body sites
102 l-time assay for the rapid identification of Burkholderia pseudomallei isolates and the evaluation of
108 Infections with the Gram-negative bacterium Burkholderia pseudomallei (melioidosis) are associated w
109 organism and causative agent of melioidosis, Burkholderia pseudomallei Passive-transfer experiments a
111 icated a protein microarray containing 1,205 Burkholderia pseudomallei proteins, probed it with 88 me
112 BPSL1549, a protein of unknown function from Burkholderia pseudomallei, reveals a similarity to Esche
113 Previous studies have demonstrated that Burkholderia pseudomallei secretes protease, lipase, and
114 Host & Microbe, Wong et al. (2015) show that Burkholderia pseudomallei senses host cytosolic glutathi
116 PCR amplification of 14 Ara(+) and 8 Ara(-) Burkholderia pseudomallei strains showed that type III s
117 sis approach, we have identified a mutant of Burkholderia pseudomallei that is auxotrophic for branch
118 holderia thailandensis is closely related to Burkholderia pseudomallei, the causative agent of melioi
123 better understanding of adaptive immunity to Burkholderia pseudomallei, the causative agent of melioi
130 agnostic patterns for fighting diseases like Burkholderia pseudomallei using biomarkers involves two
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。